BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Catalent, Inc. Reports Second Quarter Fiscal 2022 Results

  Catalent, Inc. today announced financial results for the second quarter of fiscal 2022, which ended December 31, 2021.

  February 1, 2022

   · 

  25 min read
• Deals

  Waters Acquires Charge Detection Mass Spectrometry Technology to Broaden its Application in Cell and Gene Therapy

  Waters has acquired technology assets and intellectual property rights of Megadalton Solutions, an early-stage developer of charge detection mass spectrometry (CDMS).

  February 1, 2022

   · 

  2 min read
• BioMidwest

  Barbara Ann Karmanos Cancer Institute and Network named Recipient of the American Cancer Society Lodging Grant for Cancer Patients Receiving Treatment

  The Barbara Ann Karmanos Cancer Institute was recently awarded a $50,000 lodging grant by the American Cancer Society to help eliminate the financial barriers of cancer treatment.

  February 1, 2022

   · 

  2 min read
• Business

  SI-BONE To Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022

  SI-BONE, Inc. today announced it will report financial results for the fourth quarter and full year 2021 after market close on Monday, February 28, 2022.

  February 1, 2022

   · 

  1 min read
• Biotech Bay

  Allakos to Host Investor Day on February 15

  Allakos Inc., a biotechnology company developing lirentelimab for the treatment of eosinophil and mast cell-related diseases, announced that it will host an Investor Day on February 15th starting at 8:00 am ET.

  February 1, 2022

   · 

  3 min read
• Business

  TRANSPLANT GENOMICS WELCOMES CHIEF MEDICAL OFFICER JON FRIEDMAN, MD, FAST

  Dr. Friedman brings 30 years of success in delivering value for patients, healthcare providers, and payors to help Transplant Genomics deliver on its mission.

  February 1, 2022

   · 

  2 min read
• Pharm Country

  Jasper Health Raises $25 Million in Series A Funding to Increase Access to Comprehensive Cancer Experience and Care Navigation Platform

  Jasper Health today announced a $25 million Series A funding round led by General Catalyst.

  February 1, 2022

   · 

  4 min read
• Bio NC

  Biofidelity Raises $23M in Series A+ Financing led by Octopus Ventures to Launch ASPYRE Technology

  Biofidelity, a pioneer in precision cancer diagnostics, has successfully completed a heavily oversubscribed $23 million Series A+ investment round, led by Octopus Ventures and backed by SBI Investment Co. Ltd. and existing investors.

  February 1, 2022

   · 

  3 min read
• Business

  Cyclica Recruits Big Pharma Veteran Michael Palovich as Chief Science Officer to Advance Robust Drug Discovery Pipeline

  Cyclica Inc. welcomes drug discovery veteran Michael (Mike) Palovich as Chief Science Officer, Head of Drug Discovery.

  February 1, 2022

   · 

  2 min read
• Genetown

  Acer Therapeutics to Participate in 2022 BIO CEO & Investor Conference

  Acer Therapeutics Inc. announced that Acer’s management team will virtually participate in the BIO CEO & Investor Conference on February 14-17, 2022.

  February 1, 2022

   · 

  1 min read